AHA today urged the Agency for Healthcare Research and Quality to reconsider its decision to shut down the National Guidelines Clearinghouse. “The NGC has been a valuable resource to clinicians and health care organizations in the United States and across the world for two decades,” AHA wrote. “It provides easy access to evidence-based guidelines for practice, helping busy clinicians develop plans of care for patients, allowing health care organizations to create standard protocols for practice, embed decision support for their clinicians, and reduce practice variation to ensure the best outcomes for their patients. It is regrettable that budget cuts have forced AHRQ to make the difficult decision to eliminate this valuable resource, much to the detriment of patients and the providers who treat them. We urge you to reconsider this decision.” 

Related News Articles

Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
There have been 8,064 reported cases of whooping cough in the U.S. so far this year, according to the latest data from the Centers for Disease Control and…
Headline
A study published April 17 by BMC Infectious Diseases found increased incidents of Acinetobacter baumannii and carbapenem-resistant A. baumannii infections…
Headline
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue…
Headline
Achieving operational and survey readiness on day one is an issue that many health care facilities professionals continue to grapple with, according to…